1646 / 1726
Subgroup analysis (distant control)
•
394 consecutive patients from 7 centres treated
with RCHT and IGBT
(5 centers enrolled selected patients)
•
Two groups based on univariate analysis
Low risk: 1B, 2A, 2B, 3A &N0, 1BN+
High risk: 2A-2B & N+, any 3B-4A